Safety in Preanalytics and the Significance of Training
Professor Dr. Waleed Al Tamimi presents:
- Release Date: 07.05.2025
- Duration: 26 minutes
- Guest: Dr. Waleed Al Tamimi
- Host: Director Global Market Management Helene Ivanov
- Introduction: Professor Dr. Waleed Al Tamimi, head consultant of the clinical biochemistry lab at the King Abdulaziz Medical City in Saudi Arabia, shares his expertise and experience in converting to using safety products to promote healthcare worker safety and risk management.
Timestamps for Episode 4
- 01:15 - Legislation and guidelines in Saudia Arabia on promotion of safety products
- 03:44 - What products are currently preferred?
- 05:06 - Using a new device means you need training
- 06:25 - It's about more than safety, it's about preanalytics
- 09:46 - Does implementation of safety products genuinely contribute to reduction of needlesticks?
- 11:29 - Do the benefits of safety products justify the higher price?
- 15:08 - What are the top 5 measures to prioritize in a safety campaign?
- 19:32 - Both the burden and workload in the health system are increasing
What You Can't Miss – In a Nutshell
The importance of root cause analysis and training
- If an increase in errors is observed, for example, a spike in rejection rates due to sample quality, it is important to find out why and if needed, offer guidance and training to nurses and phlebotomists.
Encourage the reporting of needlestick injuries
- Needlestick injuries can have life-threatening consequences and a reporting system must be in place, that workers can use without fear of consequences for their jobs.
Not just training but also patience can be key
- Patience in getting to know alternative products and technologies as well as training can be the key to successful implementation of safer products.
āWe have seen a tremendous decrease in needlestick injuries by using the safe product.ā
Get the latest from our podcast
Disclaimer & Shownotes
The guests interviewed in this podcast share their individual experiences with the use of our or comparable products and/or services. The opinions expressed are those of the interviewee and do not claim to represent the opinions or views of Greiner Bio-One. This information partially reflects the opinions of our customers and/or the experiences of individuals and does not claim to represent the opinions or views of Greiner Bio-One.
Products from Greiner Bio-One should only be used by appropriately trained medical professionals in accordance with the relevant instructions for use (IFU). A list of indications, contraindications, precautions, and warnings can be found in the instructions for use that accompany each product or can be downloaded from our website www.gbo.com (Download Center). For further information, please contact your local Greiner Bio-One distributor or visit our website.
All information is provided without guarantee despite careful processing. Liability, warranty, or guarantee of Greiner Bio-One GmbH is excluded. All rights, errors, and changes are reserved. Unless otherwise stated, Greiner Bio-One GmbH holds all copyrights and/or other (usage) rights in the present documents, especially to trademarks, such as the listed (word-image) marks, logos. Any use, reproduction, or other use of the rights of Greiner Bio-One GmbH is expressly prohibited.
Publisher and editor: Greiner Bio-One GmbH, Bad Haller Str. 32, 4550 KremsmĆ¼nster, Austria.
